BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2010
View Archived Issues
LMV-601 is potently active against HSV and HPV in preclinical studies
Read More
Neutrophil elastase inhibitor AZD-9668 shows promise in COPD
Read More
Tuberculosis candidate PNU-100480 is well tolerated in healthy volunteers
Read More
Pfizer discloses new activators of glucokinase
Read More
FDA provides guidance to Celsion for ThermoDox NDA
Read More
SNPs in PIK3C2B gene correlate with risk of Parkinson's disease
Read More
B-27-PD enters phase I/II trial in chronic noninfectious uveitis
Read More
BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates
Read More
Artemether sublingual spray is safe and efficacious in children with severe malaria
Read More
Cosmo Pharma's CB-03-01 effective in proof-of-concept alopecia study
Read More
FDA orphan drug status for rozrolimupab in immune thrombocytopenia
Read More
FDA grants orphan drug status to Prolor's longer-acting human growth hormone
Read More
Viralytics advances phase I trial of coxsackievirus A21
Read More
Bionomics receives approval for two phase Ib trials of BNC-210 in France
Read More
Meda completes acquisition of Alaven
Read More
Daiichi Sankyo discovers new PPAR-gamma agonists
Read More
Starpharma and Lilly collaborate on dendrimer-drug conjugate development
Read More
UCB patents new inhibitors of PI3K isoforms
Read More
U.S. researchers claim new DNA topoisomerase 1 inhibitors
Read More
Flu vaccine LIQ-001 advances to clinic in phase I trial
Read More
Phase III trial of aripiprazole in schizophrenia meets efficacy criteria
Read More
Akebia Therapeutics presents data from phase IIa AKB-6548 trial
Read More
Japanese scientists disclose new diagnostics for Alzheimer's disease
Read More
Altravax receives NIH grants for research on vaccines for HIV-1
Read More
Johnson & Johnson to acquire all outstanding shares of Crucell
Read More